Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1209

1.

Noninvasive assessment of left-ventricular diastolic electromechanical coupling in hypertensive heart disease.

Saito Y, Yamada H, Kusunose K, Saito K, Sata M.

J Echocardiogr. 2019 Feb 12. doi: 10.1007/s12574-019-00421-4. [Epub ahead of print]

PMID:
30756346
2.

Recurrent venous thromboembolism after discontinuation of rivaroxaban therapy in a patient with antiphospholipid syndrome.

Yagi S, Nishiyama S, Abe T, Sata M.

BMJ Case Rep. 2019 Jan 10;12(1). pii: bcr-2018-227663. doi: 10.1136/bcr-2018-227663.

PMID:
30635311
3.

Distinct Incidence of Takotsubo Syndrome Between Amyotrophic Lateral Sclerosis and Synucleinopathies: A Cohort Study.

Izumi Y, Miyamoto R, Fujita K, Yamamoto Y, Yamada H, Matsubara T, Unai Y, Tsukamoto A, Takamatsu N, Nodera H, Hayashi S, Oda M, Mori A, Nishida Y, Watanabe S, Ogawa H, Uehara H, Murayama S, Sata M, Kaji R.

Front Neurol. 2018 Dec 13;9:1099. doi: 10.3389/fneur.2018.01099. eCollection 2018.

4.

Efficacy and safety of alirocumab 150mg every 4 weeks in hypercholesterolemic patients on non-statin lipid-lowering therapy or lowest strength dose of statin: ODYSSEY NIPPON.

Teramoto T, Kiyosue A, Ishigaki Y, Harada-Shiba M, Kawabata Y, Ozaki A, Baccara-Dinet MT, Sata M.

J Cardiol. 2019 Mar;73(3):218-227. doi: 10.1016/j.jjcc.2018.10.004. Epub 2018 Nov 30.

5.

Left atrial functional response after a marathon in healthy amateur volunteers.

Hirata Y, Kusunose K, Yamada H, Morita S, Torii Y, Nishio S, Zheng R, Saijo Y, Fukuda D, Yagi S, Soeki T, Sata M.

Int J Cardiovasc Imaging. 2018 Nov 23. doi: 10.1007/s10554-018-1502-2. [Epub ahead of print]

PMID:
30470971
6.

Activation of Toll-Like Receptor 9 Impairs Blood Flow Recovery After Hind-Limb Ischemia.

Nishimoto S, Aini K, Fukuda D, Higashikuni Y, Tanaka K, Hirata Y, Yagi S, Kusunose K, Yamada H, Soeki T, Shimabukuro M, Sata M.

Front Cardiovasc Med. 2018 Oct 16;5:144. doi: 10.3389/fcvm.2018.00144. eCollection 2018.

7.

Simultaneous Pulmonary Arterial and Venous Round Structures in Pulmonary Aspergillosis.

Yagi S, Yamazaki H, Nishio S, Kusunose K, Yamada H, Sata M.

Circ J. 2018 Nov 3. doi: 10.1253/circj.CJ-18-0898. [Epub ahead of print] No abstract available.

8.

Inhibition of Atherosclerotic Plaque Development by Oral Administration of α-Glucosyl Hesperidin and Water-Dispersible Hesperetin in Apolipoprotein E Knockout Mice.

Sugasawa N, Katagi A, Kurobe H, Nakayama T, Nishio C, Takumi H, Higashiguchi F, Aihara KI, Shimabukuro M, Sata M, Kitagawa T.

J Am Coll Nutr. 2019 Jan;38(1):15-22. doi: 10.1080/07315724.2018.1468831. Epub 2018 Oct 15.

PMID:
30321103
9.

Usefulness of Epicardial Adipose Tissue Volume to Predict Recurrent Atrial Fibrillation After Radiofrequency Catheter Ablation.

Maeda M, Oba K, Yamaguchi S, Arasaki O, Sata M, Masuzaki H, Shimabukuro M.

Am J Cardiol. 2018 Nov 15;122(10):1694-1700. doi: 10.1016/j.amjcard.2018.08.005. Epub 2018 Aug 21.

PMID:
30244845
10.

Epicardial Fat and Pericardial Fat Surrounding the Heart Have Different Characteristics.

Hirata Y, Yamada H, Sata M.

Circ J. 2018 Sep 25;82(10):2475-2476. doi: 10.1253/circj.CJ-18-0923. Epub 2018 Sep 5. No abstract available.

11.

Right Ventricular Function and Beneficial Effects of Cardiac Rehabilitation in Patients With Systolic Chronic Heart Failure.

Kusunose K, Seno H, Yamada H, Nishio S, Torii Y, Hirata Y, Saijo Y, Ise T, Yamaguchi K, Fukuda D, Yagi S, Soeki T, Wakatsuki T, Sata M.

Can J Cardiol. 2018 Oct;34(10):1307-1315. doi: 10.1016/j.cjca.2018.06.003. Epub 2018 Jun 7.

PMID:
30146462
12.

Association of Decreased Docosahexaenoic Acid Level After Statin Therapy and Low Eicosapentaenoic Acid Level with In-Stent Restenosis in Patients with Acute Coronary Syndrome.

Yagi S, Kondo D, Ise T, Fukuda D, Yamaguchi K, Wakatsuki T, Kawabata Y, Ito H, Saijo Y, Seno H, Sutou K, Ueno R, Todoroki T, Kusunose K, Matsuura T, Tobiume T, Yamada H, Soeki T, Shimabukuro M, Aihara KI, Akaike M, Sata M.

J Atheroscler Thromb. 2018 Aug 21. doi: 10.5551/jat.44735. [Epub ahead of print]

13.

Severe upper gastrointestinal disorders in pembrolizumab-treated non-small cell lung cancer patient.

Onuki T, Morita E, Sakamoto N, Nagai Y, Sata M, Hagiwara K.

Respirol Case Rep. 2018 Aug 1;6(6):e00334. doi: 10.1002/rcr2.334. eCollection 2018 Aug.

14.

Endothelial Dysfunction, Increased Arterial Stiffness, and Cardiovascular Risk Prediction in Patients With Coronary Artery Disease: FMD-J (Flow-Mediated Dilation Japan) Study A.

Maruhashi T, Soga J, Fujimura N, Idei N, Mikami S, Iwamoto Y, Iwamoto A, Kajikawa M, Matsumoto T, Oda N, Kishimoto S, Matsui S, Hashimoto H, Aibara Y, Mohamad Yusoff F, Hidaka T, Kihara Y, Chayama K, Noma K, Nakashima A, Goto C, Tomiyama H, Takase B, Kohro T, Suzuki T, Ishizu T, Ueda S, Yamazaki T, Furumoto T, Kario K, Inoue T, Koba S, Watanabe K, Takemoto Y, Hano T, Sata M, Ishibashi Y, Node K, Maemura K, Ohya Y, Furukawa T, Ito H, Ikeda H, Yamashina A, Higashi Y.

J Am Heart Assoc. 2018 Jul 12;7(14). pii: e008588. doi: 10.1161/JAHA.118.008588.

15.

A clinical application of preload stress echocardiography for predicting future hemodynamic worsening in patients with early-stage heart failure.

Saijo Y, Yamada H, Kusunose K, Bando M, Nishio S, Torii Y, Hirata Y, Seno H, Matsuura T, Ise T, Tobiume T, Yamaguchi K, Yagi S, Soeki T, Wakatsuki T, Sata M.

Echocardiography. 2018 Oct;35(10):1587-1595. doi: 10.1111/echo.14098. Epub 2018 Jul 13.

PMID:
30005132
16.

Pharmacokinetics and Safety of DS-8500a, an Antidiabetic Drug, in Japanese Subjects with Hepatic or Renal Impairment: A Single-Center, Open-Label, Single-Dose Study.

Kato M, Ishizuka H, Taguchi T, Shiosakai K, Kamiyama E, Sata M, Yoshida T.

Adv Ther. 2018 Aug;35(8):1239-1250. doi: 10.1007/s12325-018-0739-4. Epub 2018 Jul 2.

PMID:
29968010
17.

Ticagrelor, a P2Y12 antagonist, attenuates vascular dysfunction and inhibits atherogenesis in apolipoprotein-E-deficient mice.

Ganbaatar B, Fukuda D, Salim HM, Nishimoto S, Tanaka K, Higashikuni Y, Hirata Y, Yagi S, Soeki T, Sata M.

Atherosclerosis. 2018 Aug;275:124-132. doi: 10.1016/j.atherosclerosis.2018.05.053. Epub 2018 May 31.

PMID:
29902700
18.

Cross-sectional and longitudinal associations between serum uric acid and endothelial function in subjects with treated hypertension.

Tanaka A, Kawaguchi A, Tomiyama H, Ishizu T, Matsumoto C, Higashi Y, Takase B, Suzuki T, Ueda S, Yamazaki T, Furumoto T, Kario K, Inoue T, Koba S, Takemoto Y, Hano T, Sata M, Ishibashi Y, Maemura K, Ohya Y, Furukawa T, Ito H, Yamashina A, Node K.

Int J Cardiol. 2018 Dec 1;272:308-313. doi: 10.1016/j.ijcard.2018.06.017. Epub 2018 Jun 6.

PMID:
29895425
19.

Clinical, Electrocardiographic, and Echocardiographic Parameter Combination Predicts the Onset of Atrial Fibrillation.

Soeki T, Matsuura T, Tobiume T, Bando S, Matsumoto K, Nagano H, Uematsu E, Kusunose K, Ise T, Yamaguchi K, Yagi S, Fukuda D, Yamada H, Wakatsuki T, Shimabukuro M, Sata M.

Circ J. 2018 Aug 24;82(9):2253-2258. doi: 10.1253/circj.CJ-17-0758. Epub 2018 May 30.

20.

Effect of the Epicardial Adipose Tissue Volume on the Prevalence of Paroxysmal and Persistent Atrial Fibrillation.

Oba K, Maeda M, Maimaituxun G, Yamaguchi S, Arasaki O, Fukuda D, Yagi S, Hirata Y, Nishio S, Iwase T, Takao S, Kusunose K, Yamada H, Soeki T, Wakatsuki T, Harada M, Masuzaki H, Sata M, Shimabukuro M.

Circ J. 2018 Jun 25;82(7):1778-1787. doi: 10.1253/circj.CJ-18-0021. Epub 2018 May 25.

21.

Prognostic Value of Frailty and Diastolic Dysfunction in Elderly Patients.

Kusunose K, Okushi Y, Yamada H, Nishio S, Torii Y, Hirata Y, Saijo Y, Ise T, Yamaguchi K, Yagi S, Soeki T, Wakatsuki T, Sata M.

Circ J. 2018 Jul 25;82(8):2103-2110. doi: 10.1253/circj.CJ-18-0017. Epub 2018 Apr 28.

22.

Protease-Activated Receptor-2 Plays a Critical Role in Vascular Inflammation and Atherosclerosis in Apolipoprotein E-Deficient Mice.

Hara T, Phuong PT, Fukuda D, Yamaguchi K, Murata C, Nishimoto S, Yagi S, Kusunose K, Yamada H, Soeki T, Wakatsuki T, Imoto I, Shimabukuro M, Sata M.

Circulation. 2018 Oct 16;138(16):1706-1719. doi: 10.1161/CIRCULATIONAHA.118.033544.

PMID:
29700120
23.

Minimal Shortening of Leukocyte Telomere Length Across Age Groups in a Cross-Sectional Study for Carriers of a Longevity-Associated FOXO3 Allele.

Davy PMC, Willcox DC, Shimabukuro M, Donlon TA, Torigoe T, Suzuki M, Higa M, Masuzaki H, Sata M, Chen R, Murkofsky RL, Morris BJ, Lim E, Allsopp RC, Willcox BJ.

J Gerontol A Biol Sci Med Sci. 2018 Oct 8;73(11):1448-1452. doi: 10.1093/gerona/gly071.

PMID:
29688278
24.

The Prevalence and Implication of Zinc Deficiency in Patients With Chronic Liver Disease.

Katayama K, Kawaguchi T, Shiraishi K, Ito T, Suzuki K, Koreeda C, Ohtake T, Iwasa M, Tokumoto Y, Endo R, Kawamura N, Shiraki M, Hanai T, Habu D, Tsuruta S, Sakai H, Miwa Y, Kawada N, Kato A, Takei Y, Mine T, Kohgo Y, Seki T, Sata M, Ito Y, Fukui K, Nishiguchi S, Moriwaki H, Suzuki K.

J Clin Med Res. 2018 May;10(5):437-444. doi: 10.14740/jocmr3374w. Epub 2018 Mar 16.

25.

Local Thickness of Epicardial Adipose Tissue Surrounding the Left Anterior Descending Artery Is a Simple Predictor of Coronary Artery Disease - New Prediction Model in Combination With Framingham Risk Score.

Maimaituxun G, Shimabukuro M, Fukuda D, Yagi S, Hirata Y, Iwase T, Takao S, Matsuura T, Ise T, Kusunose K, Tobiume T, Yamaguchi K, Yamada H, Soeki T, Wakatsuki T, Harada M, Sata M.

Circ J. 2018 Apr 25;82(5):1369-1378. doi: 10.1253/circj.CJ-17-1289. Epub 2018 Mar 21.

26.

An Occluded Hooklet of an Embedded Inferior Vena Cava Filter.

Yagi S, Yamamoto Y, Nishiyama S, Sata M.

Intern Med. 2018 Aug 1;57(15):2275-2276. doi: 10.2169/internalmedicine.0505-17. Epub 2018 Mar 9. No abstract available.

27.

Roles of Perivascular Adipose Tissue in the Pathogenesis of Atherosclerosis.

Tanaka K, Sata M.

Front Physiol. 2018 Feb 13;9:3. doi: 10.3389/fphys.2018.00003. eCollection 2018. Review.

28.

Successful Treatment of Oral Lichen Planus with Direct-Acting Antiviral Agents after Liver Transplantation for Hepatitis C Virus-Associated Hepatocellular Carcinoma.

Nagao Y, Nakasone K, Maeshiro T, Nishida N, Kimura K, Kawahigashi Y, Tanaka Y, Sata M.

Case Rep Gastroenterol. 2017 Nov 29;11(3):701-710. doi: 10.1159/000484132. eCollection 2017 Sep-Dec.

29.

Provocation of clinically significant left ventricular outflow tract obstruction by postural change in patients with sigmoid septum.

Hirata Y, Yamada H, Kusunose K, Nishio S, Torii Y, Horike Y, Sata M.

J Echocardiogr. 2018 Dec;16(4):173-174. doi: 10.1007/s12574-018-0372-x. Epub 2018 Jan 31. No abstract available.

PMID:
29388159
30.

Inhibition of activated factor X by rivaroxaban attenuates neointima formation after wire-mediated vascular injury.

Hara T, Fukuda D, Tanaka K, Higashikuni Y, Hirata Y, Yagi S, Soeki T, Shimabukuro M, Sata M.

Eur J Pharmacol. 2018 Feb 5;820:222-228. doi: 10.1016/j.ejphar.2017.12.037. Epub 2017 Dec 18.

PMID:
29269019
31.

Effects of Ezetimibe-Statin Combination Therapy on Coronary Atherosclerosis in Acute Coronary Syndrome.

Hibi K, Sonoda S, Kawasaki M, Otsuji Y, Murohara T, Ishii H, Sato K, Koshida R, Ozaki Y, Sata M, Morino Y, Miyamoto T, Amano T, Morita S, Kozuma K, Kimura K, Fujiwara H; Ezetimibe-ACS Investigators.

Circ J. 2018 Feb 23;82(3):757-766. doi: 10.1253/circj.CJ-17-0598. Epub 2017 Dec 7.

32.

Brachial artery diameter as a marker for cardiovascular risk assessment: FMD-J study.

Maruhashi T, Soga J, Fujimura N, Idei N, Mikami S, Iwamoto Y, Iwamoto A, Kajikawa M, Matsumoto T, Oda N, Kishimoto S, Matsui S, Hashimoto H, Aibara Y, Yusoff FM, Hidaka T, Kihara Y, Chayama K, Noma K, Nakashima A, Goto C, Tomiyama H, Takase B, Kohro T, Suzuki T, Ishizu T, Ueda S, Yamazaki T, Furumoto T, Kario K, Inoue T, Koba S, Watanabe K, Takemoto Y, Hano T, Sata M, Ishibashi Y, Node K, Maemura K, Ohya Y, Furukawa T, Ito H, Ikeda H, Yamashina A, Higashi Y.

Atherosclerosis. 2018 Jan;268:92-98. doi: 10.1016/j.atherosclerosis.2017.11.022. Epub 2017 Nov 22.

PMID:
29195110
33.

Predictors for the Treatment Effect of Sodium Glucose Co-transporter 2 Inhibitors in Patients with Type 2 Diabetes Mellitus.

Yagi S, Aihara KI, Kondo T, Kurahashi K, Yoshida S, Endo I, Fukuda D, Nakaya Y, Suwaki KI, Takeji T, Wada T, Salim HM, Hama S, Matsuura T, Ise T, Kusunose K, Yamaguchi K, Tobiume T, Yamada H, Soeki T, Wakatsuki T, Matsuhisa M, Shimabukuro M, Akaike M, Sata M.

Adv Ther. 2018 Jan;35(1):124-134. doi: 10.1007/s12325-017-0639-z. Epub 2017 Nov 28.

PMID:
29185199
34.

Correction to: Treatment with the PPARγ Agonist Pioglitazone in the Early Post-ischemia Phase Inhibits Pro-inflammatory Responses and Promotes Neurogenesis Via the Activation of Innate- and Bone Marrow-Derived Stem Cells in Rats.

Kinouchi T, Kitazato KT, Shimada K, Yagi K, Tada Y, Matsushita N, Kurashiki Y, Satomi J, Sata M, Nagahiro S.

Transl Stroke Res. 2018 Jun;9(3):317. doi: 10.1007/s12975-017-0589-4.

PMID:
29177991
35.

Longitudinal association among endothelial function, arterial stiffness and subclinical organ damage in hypertension.

Tomiyama H, Ishizu T, Kohro T, Matsumoto C, Higashi Y, Takase B, Suzuki T, Ueda S, Yamazaki T, Furumoto T, Kario K, Inoue T, Koba S, Takemoto Y, Hano T, Sata M, Ishibashi Y, Node K, Maemura K, Ohya Y, Furukawa T, Ito H, Yamashina A.

Int J Cardiol. 2018 Feb 15;253:161-166. doi: 10.1016/j.ijcard.2017.11.022. Epub 2017 Nov 12.

36.

Treatment with the PPARγ Agonist Pioglitazone in the Early Post-ischemia Phase Inhibits Pro-inflammatory Responses and Promotes Neurogenesis Via the Activation of Innate- and Bone Marrow-Derived Stem Cells in Rats.

Kinouchi T, Kitazato KT, Shimada K, Yagi K, Tada Y, Matsushita N, Kurashiki Y, Satomi J, Sata M, Nagahiro S.

Transl Stroke Res. 2018 Jun;9(3):306-316. doi: 10.1007/s12975-017-0577-8. Epub 2017 Nov 6. Erratum in: Transl Stroke Res. 2017 Nov 26;:.

37.

Edoxaban improves acute venous thromboembolism while preserving protein C and protein S levels.

Yamazaki H, Yagi S, Torii Y, Amano R, Oomichi Y, Sangawa T, Fukuda D, Kadota M, Ise T, Ueno R, Hara T, Kusunose K, Matsuura T, Tobiume T, Yamaguchi K, Yamada H, Soeki T, Wakatsuki T, Akaike M, Sata M.

J Cardiol. 2018 Mar;71(3):305-309. doi: 10.1016/j.jjcc.2017.09.009. Epub 2017 Nov 1.

PMID:
29100817
38.

Retrospective Proteomic Analysis of a Novel, Cancer Metastasis-Promoting RGD-Containing Peptide.

Tsuru M, Sata M, Tanaka M, Umeyama H, Kodera Y, Shiwa M, Aoyagi N, Yasuda K, Matsuoka K, Fukuda T, Yamana H, Nagata K.

Transl Oncol. 2017 Dec;10(6):998-1007. doi: 10.1016/j.tranon.2017.10.001. Epub 2017 Nov 2.

39.

STAT3 deficiency prevents hepatocarcinogenesis and promotes biliary proliferation in thioacetamide-induced liver injury.

Abe M, Yoshida T, Akiba J, Ikezono Y, Wada F, Masuda A, Sakaue T, Tanaka T, Iwamoto H, Nakamura T, Sata M, Koga H, Yoshimura A, Torimura T.

World J Gastroenterol. 2017 Oct 7;23(37):6833-6844. doi: 10.3748/wjg.v23.i37.6833.

40.

Canagliflozin reduces epicardial fat in patients with type 2 diabetes mellitus.

Yagi S, Hirata Y, Ise T, Kusunose K, Yamada H, Fukuda D, Salim HM, Maimaituxun G, Nishio S, Takagawa Y, Hama S, Matsuura T, Yamaguchi K, Tobiume T, Soeki T, Wakatsuki T, Aihara KI, Akaike M, Shimabukuro M, Sata M.

Diabetol Metab Syndr. 2017 Oct 4;9:78. doi: 10.1186/s13098-017-0275-4. eCollection 2017.

41.

Effect of Oral Care Gel for Burning Mouth Syndrome in a Patient with Hepatitis C: A Case Report.

Nagao Y, Kawahigashi Y, Kimura K, Sata M.

Case Rep Gastroenterol. 2017 Aug 17;11(2):480-487. doi: 10.1159/000479495. eCollection 2017 May-Aug.

42.

Preload Stress Echocardiography Predicts Outcomes in Patients With Preserved Ejection Fraction and Low-Gradient Aortic Stenosis.

Kusunose K, Yamada H, Nishio S, Torii Y, Hirata Y, Seno H, Saijo Y, Ise T, Yamaguchi K, Yagi S, Soeki T, Wakatsuki T, Sata M.

Circ Cardiovasc Imaging. 2017 Oct;10(10). pii: e006690. doi: 10.1161/CIRCIMAGING.117.006690.

PMID:
29021259
43.

Improved Exercise Capacity After Cardiac Rehabilitation Is Associated with Reduced Visceral Fat in Patients with Chronic Heart Failure.

Takagawa Y, Yagi S, Ise T, Ishii A, Nishikawa K, Fukuda D, Kusunose K, Matsuura T, Tobiume T, Yamaguchi K, Yamada H, Soeki T, Wakatsuki T, Shimabukuro M, Katoh S, Aihara KI, Akaike M, Sata M.

Int Heart J. 2017 Oct 21;58(5):746-751. doi: 10.1536/ihj.16-454. Epub 2017 Sep 30.

44.

Low Serum Levels of Eicosapentaenoic Acid and Docosahexaenoic Acid are Risk Factors for Cardiogenic Syncope in Patients with Brugada Syndrome.

Yagi S, Soeki T, Aihara KI, Fukuda D, Ise T, Kadota M, Bando S, Matsuura T, Tobiume T, Yamaguchi K, Kusunose K, Yamada H, Wakatsuki T, Shimabukuro M, Akaike M, Sata M.

Int Heart J. 2017 Oct 21;58(5):720-723. doi: 10.1536/ihj.16-278. Epub 2017 Sep 30.

45.

Impact of Speed-Eating Habit on Subsequent Body Mass Index and Blood Pressure Among Schoolchildren - The Ibaraki Children's Cohort Study (IBACHIL).

Yamagishi K, Sairenchi T, Sawada N, Sunou K, Sata M, Murai U, Takizawa N, Irie F, Watanabe H, Iso H, Ota H.

Circ J. 2018 Jan 25;82(2):419-422. doi: 10.1253/circj.CJ-17-0287. Epub 2017 Sep 5.

46.

Echocardiographic Epicardial Adipose Tissue Thickness Is Associated with Symptomatic Coronary Vasospasm during Provocative Testing.

Nishio S, Kusunose K, Yamada H, Hirata Y, Ise T, Yamaguchi K, Yagi S, Soeki T, Wakatsuki T, Shimabukuro M, Sata M.

J Am Soc Echocardiogr. 2017 Oct;30(10):1021-1027.e1. doi: 10.1016/j.echo.2017.06.024. Epub 2017 Aug 23.

PMID:
28843368
47.

n-3 Polyunsaturated Fatty Acids: Promising Nutrients for Preventing Cardiovascular Disease.

Yagi S, Fukuda D, Aihara KI, Akaike M, Shimabukuro M, Sata M.

J Atheroscler Thromb. 2017 Oct 1;24(10):999-1010. doi: 10.5551/jat.RV17013. Epub 2017 Aug 24. Review.

48.

Development and validation of optimal cut-off value in inter-arm systolic blood pressure difference for prediction of cardiovascular events.

Hirono A, Kusunose K, Kageyama N, Sumitomo M, Abe M, Fujinaga H, Sata M.

J Cardiol. 2018 Jan;71(1):24-30. doi: 10.1016/j.jjcc.2017.06.010. Epub 2017 Aug 19.

49.

Age-related changes in morphology of left atrial appendage in patients with atrial fibrillation.

Hirata Y, Kusunose K, Yamada H, Shimizu R, Torii Y, Nishio S, Saijo Y, Takao S, Soeki T, Sata M.

Int J Cardiovasc Imaging. 2018 Feb;34(2):321-328. doi: 10.1007/s10554-017-1232-x. Epub 2017 Aug 14.

PMID:
28808846
50.

Endothelial Function Is Impaired in Patients Receiving Antihypertensive Drug Treatment Regardless of Blood Pressure Level: FMD-J Study (Flow-Mediated Dilation Japan).

Maruhashi T, Soga J, Fujimura N, Idei N, Mikami S, Iwamoto Y, Iwamoto A, Kajikawa M, Matsumoto T, Oda N, Kishimoto S, Matsui S, Hashimoto H, Aibara Y, Yusoff FBM, Hidaka T, Kihara Y, Chayama K, Noma K, Nakashima A, Goto C, Tomiyama H, Takase B, Kohro T, Suzuki T, Ishizu T, Ueda S, Yamazaki T, Furumoto T, Kario K, Inoue T, Koba S, Watanabe K, Takemoto Y, Hano T, Sata M, Ishibashi Y, Node K, Maemura K, Ohya Y, Furukawa T, Ito H, Ikeda H, Yamashina A, Higashi Y.

Hypertension. 2017 Oct;70(4):790-797. doi: 10.1161/HYPERTENSIONAHA.117.09612. Epub 2017 Aug 14.

PMID:
28808069

Supplemental Content

Support Center